Gulf Pharmaceutical Industries P.S.C. (ADX:JULPHAR)

ADX:JULPHAR Balance Sheet

Financials in millions AED. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	218.6	147.3	204.8	92.3	159.3	73.7
Trading Asset Securities	21.3	21.3	20.5	19.5	19.5	19.7
Cash & Short-Term Investments	253.6	168.6	225.3	111.8	178.8	93.4
Cash Growth	33.47%	-25.17%	101.52%	-37.47%	91.44%	15.45%
Accounts Receivable	534.9	516.6	529	550.4	473.2	647.7
Other Receivables	-	368.6	31.9	34.8	110.9	-
Receivables	534.9	885.2	560.9	585.2	584.1	647.7
Inventory	393.4	413.7	661.7	672.8	653.9	294.3
Prepaid Expenses	-	14.1	14.8	16.2	9.5	-
Restricted Cash	20	76.2	36	-	-	-
Other Current Assets	282	474.2	82.6	76.7	73.3	103.2
Total Current Assets	1,484	2,032	1,581	1,463	1,500	1,139
Property, Plant & Equipment	252.3	314	709.1	752.3	749	901.3
Long-Term Investments	0.2	12.9	18.9	25.5	-	270.6
Other Intangible Assets	34.1	81.3	143.8	158.3	177.2	15
Long-Term Deferred Tax Assets	-	0.8	0.8	0.6	0.5	1.8
Total Assets	1,776	2,441	2,454	2,399	2,426	2,327
Accounts Payable	302.4	146.5	207.3	265.9	275.3	338.5
Accrued Expenses	-	108.2	105.9	114.9	154.6	-
Short-Term Debt	-	148.1	125.4	20.5	54.4	156.8
Current Portion of Long-Term Debt	-	152.5	90	37.5	-	234.1
Current Portion of Leases	2.1	49.4	38.6	39.2	31.9	-
Current Income Taxes Payable	15.3	5.2	7.7	5.9	5.9	-
Current Unearned Revenue	-	1.6	1.5	1.5	8.5	207
Other Current Liabilities	138.3	314.3	122.7	113.1	115.3	37
Total Current Liabilities	458.1	925.8	699.1	598.5	645.9	973.4
Long-Term Debt	263.8	612.5	765	712.5	665	220.9
Long-Term Leases	5.8	8.5	91.6	76	67.8	-
Pension & Post-Retirement Benefits	66.1	76.3	84	80.9	79.8	59.4
Long-Term Deferred Tax Liabilities	6.8	8.3	8	3.3	4	3.7
Total Liabilities	800.6	1,631	1,648	1,471	1,463	1,257
Common Stock	1,155	1,155	1,155	1,155	1,155	1,155
Retained Earnings	47.2	-119.5	-161.2	-65.8	-36.4	-107.7
Comprehensive Income & Other	-238.8	-236.7	-199.9	-173	-162.2	-146.5
Total Common Equity	963.7	799.1	794.2	916.5	956.7	901.1
Minority Interest	11.4	10.5	12	11.7	7.1	168.8
Shareholders' Equity	975.1	809.6	806.2	928.2	963.8	1,070
Total Liabilities & Equity	1,776	2,441	2,454	2,399	2,426	2,327
Total Debt	271.7	971	1,111	885.7	819.1	611.8
Net Cash (Debt)	-18.1	-802.4	-885.3	-773.9	-640.3	-518.4
Net Cash Per Share	-0.02	-0.69	-0.77	-0.67	-0.55	-0.49
Filing Date Shares Outstanding	1,158	1,155	1,155	1,155	1,155	1,155
Total Common Shares Outstanding	1,158	1,155	1,155	1,155	1,155	1,155
Working Capital	1,026	1,106	882.2	864.2	853.7	165.2
Book Value Per Share	0.83	0.69	0.69	0.79	0.83	0.78
Tangible Book Value	929.6	717.8	650.4	758.2	779.5	886.1
Tangible Book Value Per Share	0.80	0.62	0.56	0.66	0.67	0.77
Land	-	3.7	3.7	3.7	3.7	43.9
Buildings	-	368.2	508.1	508.1	505.6	623.9
Machinery	-	875.7	1,357	1,323	1,282	1,356
Construction In Progress	-	35.6	14.2	31.4	20.3	3.8
Leasehold Improvements	-	18.5	22.2	19.7	13.5	9.3

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.